BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 15227532)

  • 21. Evaluation of (+)-sparteine-like diamines for asymmetric synthesis.
    Dearden MJ; McGrath MJ; O'Brien P
    J Org Chem; 2004 Aug; 69(17):5789-92. PubMed ID: 15307761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A flexible strategy for the synthesis of tri- and tetracyclic lupin alkaloids: synthesis of (+)-cytisine, (+/-)-anagyrine, and (+/-)-thermopsine.
    Gray D; Gallagher T
    Angew Chem Int Ed Engl; 2006 Apr; 45(15):2419-23. PubMed ID: 16521145
    [No Abstract]   [Full Text] [Related]  

  • 23. Concise synthesis of (+/-)-cytisine via lithiation of N-Boc-bispidine.
    Stead D; O'Brien P; Sanderson AJ
    Org Lett; 2005 Sep; 7(20):4459-62. PubMed ID: 16178558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Core modification of cytisine: a modular synthesis.
    Hirschhäuser C; Haseler CA; Gallagher T
    Angew Chem Int Ed Engl; 2011 May; 50(22):5162-5. PubMed ID: 21520366
    [No Abstract]   [Full Text] [Related]  

  • 25. Indolizidine and quinolizidine alkaloids.
    Michael JP
    Nat Prod Rep; 1990 Dec; 7(6):485-513. PubMed ID: 2084595
    [No Abstract]   [Full Text] [Related]  

  • 26. Indolizidine and quinolizidine alkaloids.
    Michael JP
    Nat Prod Rep; 1997 Dec; 14(6):619-36. PubMed ID: 9418297
    [No Abstract]   [Full Text] [Related]  

  • 27. Cytisine for smoking cessation: a research agenda.
    Etter JF; Lukas RJ; Benowitz NL; West R; Dresler CM
    Drug Alcohol Depend; 2008 Jan; 92(1-3):3-8. PubMed ID: 17825502
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Indolizidine and quinolizidine alkaloids.
    Michael JP
    Nat Prod Rep; 2008 Feb; 25(1):139-65. PubMed ID: 18250900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Indolizidine and quinolizidine alkaloids.
    Michael JP
    Nat Prod Rep; 2004 Oct; 21(5):625-49. PubMed ID: 15459758
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Indolizidine and quinolizidine alkaloids.
    Michael JP
    Nat Prod Rep; 2007 Feb; 24(1):191-222. PubMed ID: 17268613
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A short synthesis of (+/-)-cytisine.
    Botuha C; Galley CM; Gallagher T
    Org Biomol Chem; 2004 Jul; 2(13):1825-6. PubMed ID: 15227532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advances on the Bioactivities, Total Synthesis, Structural Modification, and Structure-Activity Relationships of Cytisine Derivatives.
    Huang X; Xu H
    Mini Rev Med Chem; 2020; 20(5):369-395. PubMed ID: 31686638
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytisine: a natural product lead for the development of drugs acting at nicotinic acetylcholine receptors.
    Pérez EG; Méndez-Gálvez C; Cassels BK
    Nat Prod Rep; 2012 May; 29(5):555-67. PubMed ID: 22367109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. (-)-Cytisine and derivatives: synthesis, reactivity, and applications.
    Rouden J; Lasne MC; Blanchet J; Baudoux J
    Chem Rev; 2014 Jan; 114(1):712-78. PubMed ID: 24117010
    [No Abstract]   [Full Text] [Related]  

  • 35. Indolizidine and quinolizidine alkaloids.
    Michael JP
    Nat Prod Rep; 2001 Oct; 18(5):520-42. PubMed ID: 11699884
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.